Cargando…
Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy
PURPOSE: The purpose of this study is to report the use of intravitreal triamcinolone for treatment of cancer-associated retinopathy (CAR) refractory to systemic therapy. METHODS: This was a retrospective chart review study. RESULTS: A 67-year-old man presented with cancer-associated retinopathy wit...
Autores principales: | Huynh, Nancy, Shildkrot, Yevgeniy, Lobo, Ann-Marie, Sobrin, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438305/ https://www.ncbi.nlm.nih.gov/pubmed/22415770 http://dx.doi.org/10.1007/s12348-012-0067-9 |
Ejemplares similares
-
Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2006) -
Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
por: Shukla, Dhananjay
Publicado: (2014) -
Fulminant toxoplasmic retino-choroiditis following intravitreal triamcinolone administration
por: Rush, Ryan, et al.
Publicado: (2012) -
Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
por: Ghose, Avirupa, et al.
Publicado: (2016) -
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)